IgE clinical trials
15 active trials name this biomarker in their eligibility criteria. Describe your situation to see which ones you may be eligible for.
- Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels
- A Clinical Trial of Soluble Fiber for Asthma
- Omalizumab Weight-Based Dosing Efficacy Trial
- Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- Regeneron AA Multicenter (Dupilumab)
- Omalizumab Before Onset of Exacerbations
- Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
- Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
- Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis
- Infant Formula in Infants and Children With Cow's Milk Allergy
- Michigan Food and Atopic Dermatitis (M-FAD) Program - Molecular Analytics Project
- Beginning to Assess an Appropriate CONtrol for Oral Food Challenges in Alpha-Gal Syndrome (CoFAR-13) - BeACON4AG
- Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
- A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)
- Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)
Guides for people searching for a trial
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that name “IgE” in their eligibility criteria, at any level. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.